New combo therapy targets tough lung cancer complication
Disease control
Not yet recruiting
This study tests whether combining the drug furmonertinib with chest radiation can help control EGFR-positive lung adenocarcinoma that has spread to the lining of the lung, causing fluid buildup. About 63 adults will receive the treatment to see if it delays cancer growth. Resear…
Phase: PHASE2 • Sponsor: Jiangmen Central Hospital • Aim: Disease control
Last updated May 06, 2026 16:03 UTC